{"disease":{"id":"cervical-high-grade-squamous-intraepithelial-lesion","name":"cervical high grade squamous intraepithelial lesion"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06002126","title":"Optimization of Cervical Cancer Screening Among Women Living With HIV in Latin American Countries","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1002,"lead_sponsor_name":"Weill Medical College of Cornell University","has_results":false},{"nct_id":"NCT05210348","title":"Clinical Evaluation of Detection of High Risk HPV in Urine","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT02140021","title":"Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer","phase":"NA","overall_status":"TERMINATED","enrollment_count":409,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT03960879","title":"DNA Methylation for Screening Uterine Cervical Lesions","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT05282095","title":"Effect of HPV Integration on Prognosis of Young Women With CIN2 in China","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Fujian Maternity and Child Health Hospital","has_results":false},{"nct_id":"NCT03961191","title":"DNA Methylation for Screening Uterine Cervical Lesions: A Case-control Study","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT03721978","title":"REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":203,"lead_sponsor_name":"Inovio Pharmaceuticals","has_results":true},{"nct_id":"NCT03185013","title":"REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":201,"lead_sponsor_name":"Inovio Pharmaceuticals","has_results":true},{"nct_id":"NCT01928225","title":"Randomized, Double Blind Trial of the Quadrivalent HPV Vaccine to Improve Responses to LEEP Treatment of Cervical HSIL","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":180,"lead_sponsor_name":"University of Witwatersrand, South Africa","has_results":true},{"nct_id":"NCT03267680","title":"IRX-2 Regimen in Treating Women With Cervical Squamous Intraepithelial Neoplasia 3 or Squamous Vulvar Intraepithelial Neoplasia 3","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":10,"lead_sponsor_name":"University of Southern California","has_results":true}],"total":10},"guidelines":[],"source":"Drug Landscape verified database"}